Evaluation of Infarct Size With 3D Rotational Angiography
EVATIAR
1 other identifier
interventional
8
1 country
1
Brief Summary
The size of the infarct is particularly important prognostic marker. It is clearly established that the extent of the infarct is not only correlated to mortality, but also long-term adverse events. The evaluation of the infarct size at the acute phase of the disease is therefore an essential clinical tool to adapt the immediate treatment and follow-up of patients. It is therefore crucial to have techniques that are effective, precise, reproducible, and easily performed during the acute phase to quantify the size of the infarct following angioplasty. Myocardial scintigraphy and cardiac MRI have been the standard examinations for the evaluation of infarct size. However, these exams are difficult to perform during the acute phase of the infarct owing to difficulties in monitoring unstable patients and the limited availability of the apparatus. It is for this reason that the investigators would like to investigate the rotational angiography (RA), which is comparable to a scanner in its mode of action but does not require transfer of patients as performed using the same apparatus that used for diagnostic coronarography and therapeutic angioplasty. RA is a radiological technique that uses the system employed for coronagraph, and consists rotating the fixed C-Arm around the patient and acquisition of a series of images that are then reconstituted. The investigators propose to evaluate the size of the infarct using RA in comparison with cardiac MRI (standard examination) performed as soon as possible after RA and the investigators hope to demonstrated that RA allows the measurement of an infarct as precisely as cardiac MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2013
CompletedFirst Submitted
Initial submission to the registry
August 3, 2016
CompletedFirst Posted
Study publicly available on registry
August 5, 2016
CompletedJanuary 29, 2018
January 1, 2018
6 months
August 3, 2016
January 26, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
infarct size measured by RA
Day 1
infarct size measured by MRI
Day 4
Study Arms (1)
Patient with Myocardial Infarction
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Admitted for myocardial infarction and fulfilling the following criteria:
- Transitory or persistent ST elevation
- Coronary occlusion (TIMI 0) treated by angioplasty or thrombotic acute stenosis treated or not by angioplasty
- Planned coronarography
- With social security coverage
- Not under any legal protection;
- The consent form signed.
You may not qualify if:
- Patient unconscious or confused;
- Presenting:
- cardiogenic shock;
- or signs of cardiac insufficiency;
- or sustained cardiac arrhythmia;
- or atrial fibrillation;
- or sustained extrasystole;
- or high degree block;
- Contraindication for MRI;
- Known history of hypersensitivity to MRI contrast agent;
- Risk of pregnancy or proven pregnancy based on interview data;
- Breast feeding;
- Patient subject to legal guardianship by a court;
- Incapacity to express consent;
- Patient not or badly understanding French.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Louis Pradel
Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2016
First Posted
August 5, 2016
Study Start
March 9, 2013
Primary Completion
September 7, 2013
Study Completion
September 7, 2013
Last Updated
January 29, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share